NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SpectronRx

SpectronRx

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://www.spectronrx.com/

Last Round

Early Funding

Apr 2, 2026

Total Funding Raised

$85M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SpectronRx is a radiopharmaceutical company that provides therapeutic and diagnostic isotope solutions as a contract development and manufacturing organization (CDMO).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

radiopharmaceuticalsmedical isotopesCDMOcontract development and manufacturing organizationnuclear medicineisotope productioncold-chain logisticspharma supply chainclinical trial supportGMP manufacturingradiolabelingcyclotron servicesisotope manufacturingradioisotope supplyoncology supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpectronRx Comparables

Compare SpectronRx with similar companies based on industry and business-model similarity.

SpectronRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AtomVie Global Radiopharma Inc.
91%
Nucleus RadioPharma
88%
NorthStar Medical Radioisotopes, LLC
86%

SpectronRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 2, 2026

Key People

Founding team and executive leadership

John Zehner

President And CEO

Executive Team

Peter Webner

Chief Operating Officer

Executive Team

SpectronRx Investors

Notable investors and investment history

SpectronRx investors
InvestorRounds
OrbiMedEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    $85M raised in early funding round.

  • Jan 27, 2026

    Monthly visitors increased 124% MoM.

SpectronRx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SpectronRx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SpectronRx's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range143
Year Founded2004
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.